A mouse model for DBA that contains a loss-of-function point mutation in the Rps19 gene has been demonstrated to have a dominant negative effect [34] and, importantly, mice with Rps19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia [35]. This evidence concerns the gene RPS19 and Blackfan-Diamond anemia.